Clinical trials
Terminated Phase 3 Pulmonary Embolism trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anthos Therapeutics, Inc. | 2 |
| Hamilton Health Sciences Corporation | 2 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Cyclomedica Australia PTY Limited | 1 |
| Rajaie Cardiovascular Medical and Research Center | 1 |
| University of Rochester | 1 |
| University of Zurich | 1 |
| Wake Forest University Health Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Embolism | 10 |
| Venous Thrombosis | 6 |
| Venous Thromboembolism | 5 |
| Thrombosis | 2 |
| COVID-19 | 1 |
| Disease | 1 |
| Gastrointestinal Neoplasms | 1 |
| Renal Insufficiency | 1 |
| Ventricular Dysfunction, Right | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.